Recap of "The Call" - 7/1/09
Ockham's daily Recap of The Call.
Listed below are stocks that were mentioned in CNBC's The Call on Wednesday July, 1st.
As the market starts to settle in, after the often chaotic opening bell, CNBC’s The Call digs deeper into the issues that are dominating the market’s action. Hosted by Melissa Francis, Dylan Ratigan and Trish Regan, this show should give viewers an idea of what to expect from the market the rest of the day. Below are all of the stocks covered in the hour long show that begins at 11am ET.
Want to know everything that was said on The Call? Then you have to watch it. Visit CNBC for show times and channel guides.
CNBC - The Call Stock Commentary for 7/1/2009
|
11:46A, Jul. 01,2009
AMAG
$56.99 AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Incorporated (AMAG) Discussed on CNBC's The Call AMAG Pharmaceuticals, Incorporated is in the news. Find out how this impacts AMAG trading on Ockham Research. >> it feels terrific to bring this drug to patients who drug approval process is a long the reality is, for several decades, AMAG pharmaceuticals and its former incarnation was an imaging company, the development of this product is less than a decade old. And we are really looking forward to launching it in the “… And we are really looking forward to launching it in the …” |
|
11:04A, Jul. 01,2009
LNN
$36.26 Lindsay Corp.
Lindsay Corporation (LNN) Discussed on CNBC's The Call Lindsay Corporation is in the news. Find out how this impacts LNN trading on Ockham Research. Cereal for dinner, and if you're staying in, that is more likely to happen. And one buy side trader is see in terms of earnings, the consumer companies doing well, the industrials doing well, and LINDSAY CORP is one of the standouts, an infrastructure although their earnings were down 60%, they beat the street and that has I stock up higher. “… hough their earnings were down 60%, they beat the street and that has I stock up higher. …” |

